Sinovac Biotech, China NationalPharmaceutical Group (
Sinopharm), CanSinoBIO and the Chinese Academy of Sciences are in late-stage clinical trials.None of them has released detailed efficacy data.
If you want to change selection, open document below and click on "Move attachment"
Unknown titlen Thursday, yet with no detailed efficacy data. Following is what we know about China's vaccine development, efficacy data and approval timeline. Which are the most advanced? Five vaccines from <span>Sinovac Biotech, China NationalPharmaceutical Group (Sinopharm), CanSinoBIO and the Chinese Academy of Sciences are in late-stage clinical trials.None of them has released detailed efficacy data. Authorities approved a vaccine developed by Sinopharm'sBeijing affiliate on Thursday, a day after the developer saidinterim analysis of its Phase 3 trial showed 79.34% efficacy,without Summary
status | not read | | reprioritisations | |
---|
last reprioritisation on | | | suggested re-reading day | |
---|
started reading on | | | finished reading on | |
---|
Details